Migraine is a neurological illness characterized by nausea, excessive sensitivity to sound and light, vomiting, and severe headache pain. The two most prevalent types of migraine are those with and without aura, often known as classical migraines and common migraines. This condition affects women more than men. Anti-inflammatory drugs (NSAIDs) such as sumatriptan, ibuprofen, anti-sickness medications, zolmitriptan, aspirin, naproxen, and many other treatments are used to treat or alleviate migraine symptoms. Migraine symptoms can appear in childhood or adulthood and continue through four stages: prodrome, aura, headache, and postdrome. Aura, which happens before or during a migraine, is a nervous system symptom that usually results in blurry vision such as zigzag vision or flashes of light. This visual disturbance causes 20 to 60 minutes of loss of vision, as well as pins and needles sensations in the arms. Moreover, it may cause trouble speaking and involuntary motions of the body.
Migraines are caused by alcoholic beverages, hormonal changes in the women’s body, drugs such as oral contraceptives and vasodilators, and salty and processed foods. For instance, Nitroglycerin can develop migraines. The latest technologies, such as a new, mobile phone-controlled wireless patch that employs electrical pulses to relieve migraine symptoms, will be transformational for migraine patients.
To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/575
Migraine drugs market taxonomy
Global Migraine Drugs Market by Drugs Type:
- Painkillers
- Ergotamine
- Triptans
- Ant nausea drugs
- Opioids
- Beta-Blockers
- Calcium Channel Blocker
- Antidepressants
Global Migraine Drugs Market by Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
New medications are expected to drive the global migraine drug market growth over the forecast period.
The introduction of new medications into the market is expected to drive the global margarine drugs market during the forecast period. For instance, the U.S. Food and Drug Administration approved the Indian Drugmaker Zydus Cadila’s final approval to commercialize Eletriptan Hydrobromide tablets (40 mg and 20 mg) on June 20, 2017, and is used to treat migraines.
Moreover, on June 21, 2017, the European Medicines Agency filed the Erenumab drug of Novartis, an Indian Drugmaker. This is expected to spur other drug manufacturers to race to find a new migraine medication.
Teva Pharmaceuticals Industries Ltd. is an Israeli global biopharmaceutical company that expects the U.S. Food and Drug Administration to approve fremanezumab (TEV-48125) in 2017. This medicine will be used to treat episodic migraines as well as chronic migraines, and it is expected to reach the market in 2018.
Migraine disorders are one of the most common nervous system illnesses, affecting over half of the adult population. Moreover, North America has the highest proportion of the migraine drug market due to its significant aging population; according to the U.S. Census Bureau, the aging population was around 14.1 % in 2013. According to the World Health Organization, it was reported that 50 % of migraine problems were identified worldwide, with a higher percentage of these diseases found in women due to hormonal factors in 2016. Furthermore, the National Headache Foundation (NHF) reports that people in the U.S. spend around US$ 4 billion per year on medicines to manage migraine symptoms. Increased awareness regarding migraine therapy medications, as well as technological advancements in developing migraine drugs, are factors driving the global migraine drugs market growth over the forecast period.
To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/575
According to the Migraine Research Foundation (MRF), migraine is a widespread neurological disorder that affects 38 Mn people in the U.S., including children, men, and women, and 1000 Mn people worldwide in 2017. Drinking alcohol, as well as an increase in the use of oral contraceptives, greatly increases the cases of migraine disorder.
Migraine Drugs Market Key Players Includes:
Market players increasing emphasis on drug research and development is expected to boost the global migraine drugs market growth over the forecast period.
Some of the major players operating in the global migraine drugs market are Aeriel BioPharma, Pfizer Inc., AstraZeneca plc, Valeant Pharmaceuticals International, Inc., CoLucid Pharmaceuticals Inc., Johnson & Johnson, Aegis Therapeutics Llc, Luitpold Pharmaceuticals, GlaxoSmithKline plc., Astellas Pharma Inc., Kowa Pharmaceuticals America, WINSTON PHARMACEUTICALS, Inc., Alder BioPharmaceuticals Inc., Amgen Inc., Endo International plc, Abbott Laboratories, Teva Pharmaceutical Industries ltd., IntelGenx Corp., Dr. Reddy’s Laboratories Ltd., and Zogenix Inc.
Migraine Drugs Market Taxonomy:
Global Migraine Drugs Market by Drugs Type:
- Ergotamine
- Triptans
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Others
Global Migraine Drugs Market by Route of Administration:
- Oral
- Parenteral
Global Migraine Drugs Market by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
To Direct Purchase this Premium Research Report – https://www.coherentmarketinsights.com/insight/buy-now/575
Table of Content:
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
- Market Overview
o Report Description
- Market Definition and Scope
o Executive Summary
- Market Snippet By Product Type
- Market Snippet By Application
- Market Snippet By Technology
- Market Snippet By End User
- Market Snippet By Region
o Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
- Drivers
- Restraints
- Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis
- Global Migraine Drugs Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
- Market Share Analysis, 2016 and 2028 (%)
- Y-o-Y Growth Analysis, 2021 – 2028
- Segment Trends
o Reagents & Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
- Global Migraine Drugs Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
- Market Share Analysis, 2016 and 2028 (%)
- Y-o-Y Growth Analysis, 2021 – 2028
- Segment Trends
o Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
- Global Migraine Drugs Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
- Market Share Analysis, 2016 and 2028 (%)
- Y-o-Y Growth Analysis, 2021 – 2028
- Segment Trends
o Microarrays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
- Global Migraine Drugs Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
- Market Share Analysis, 2016 and 2028 (%)
- Y-o-Y Growth Analysis, 2021 – 2028
- Segment Trends
o Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
- Global Migraine Drugs Market, By Regions, 2021 – 2028 (US$ Million)
o Introduction
- Market Share Analysis, By Region, 2016 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 – 2028
- o North America
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- U.S.
- Canada
- o Europe
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- o Asia Pacific
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- o Latin America
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- Brazil
- Mexico
- Rest of Latin America
- o Africa
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- South Africa
- Central Africa
- North Africa
- o Middle East
- Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
- Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
- GCC
- Israel
- Rest of Middle East
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837